Vonafexor

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameVonafexor
Drug Alias NameEYP-001PXL-007EYP-001a
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsRenal Insufficiency, ChronicNephritis, HereditaryMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesTaiwan +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPoxel Sa
China Registration ClassN/A

Develop Information

Active CompaniesENYO Pharma Sa
Inactive CompaniesN/A
Active IndicationsNephritis, HereditaryMetabolic Dysfunction-Associated Steatotic Liver DiseaseHepatitis B, Chronic
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A